These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8905332)

  • 1. Neuropeptide Y release and contractile properties: differences between canine veins and arteries.
    Hunter LW; Tyce GM; Rorie DK
    Eur J Pharmacol; 1996 Oct; 313(1-2):79-87. PubMed ID: 8905332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.
    Racchi H; Irarrázabal MJ; Howard M; Morán S; Zalaquett R; Huidobro-Toro JP
    Br J Pharmacol; 1999 Mar; 126(5):1175-85. PubMed ID: 10205006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
    Ralevic V; Edvinsson L; Burnstock G
    Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
    Pernow J; Svenberg T; Lundberg JM
    Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotransmission from sympathetic vasoconstrictor neurons: differences in guinea-pig mesenteric artery and vein.
    Smyth L; Bobalova J; Ward SM; Keef KD; Mutafova-Yambolieva VN
    Auton Neurosci; 2000 Dec; 86(1-2):18-29. PubMed ID: 11269921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
    Pernow J; Saria A; Lundberg JM
    Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
    Donoso MV; Steiner M; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries.
    Prieto D; Buus CL; Mulvany MJ; Nilsson H
    Br J Pharmacol; 2000 Apr; 129(8):1689-99. PubMed ID: 10780975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F; Argiolas L; Ruvolo G; del Basso P
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
    Gradin KA; Li JY; Andersson O; Simonsen U
    J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic purinergic vasoconstriction and thermosensitivity in a canine cutaneous vein.
    Flavahan NA; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):784-9. PubMed ID: 3795041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide-dependent and -independent modulation of sympathetic vasoconstriction in the human saphenous vein.
    Fabi F; Argiolas L; Chiavarelli M; Del Basso P
    Eur J Pharmacol; 1996 Aug; 309(1):41-50. PubMed ID: 8864692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation.
    Racchi H; Schliem AJ; Donoso MV; Rahmer A; Zúñiga A; Guzmán S; Rudolf K; Huidobro-Toro JP
    Eur J Pharmacol; 1997 Jun; 329(1):79-83. PubMed ID: 9218687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from the early non-obese diabetic mouse.
    Gradin KA; Zhu H; Jeansson M; Simonsen U
    Eur J Pharmacol; 2006 Jun; 539(3):184-91. PubMed ID: 16707122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered neuropeptide Y Y1 responses in mesenteric arteries in rats with congestive heart failure.
    Bergdahl A; Nilsson T; Sun XY; Hedner T; Edvinsson L
    Eur J Pharmacol; 1998 Nov; 360(2-3):165-73. PubMed ID: 9851583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of sympathetic neurotransmission by neuropeptide Y Y2 receptors in rats and guinea pigs.
    Potter EK; Tripovic D
    Exp Brain Res; 2006 Aug; 173(2):346-52. PubMed ID: 16733694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of neuropeptide Y in sympathetic vascular control of skeletal muscle in vivo.
    Kahan T; Pernow J; Schwieler J; Lundberg JM; Hjemdahl P; Wallin BG
    J Hypertens Suppl; 1988 Dec; 6(4):S532-4. PubMed ID: 2853756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.